首页> 外文期刊>Bone >Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children.
【24h】

Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children.

机译:易骨折儿童的低密度脂蛋白受体相关蛋白5(LRP5)变异。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Recent studies have confirmed that the low-density lipoprotein receptor-related protein 5 gene (LRP5), plays a role in bone mass accrual and in susceptibility to osteoporotic fractures in adults. This study evaluated whether LRP5 variation is implicated in childhood fractures. PATIENTS AND METHODS: During an epidemiological study on childhood fractures, comprising 1390 consecutive Finnish children with an acute fracture, we recruited fracture-prone 4-16 years old children, who had a history of at least two low-energy long bone fractures before age 10 years or three low-energy long bone fractures before age 16 years, and/or at least one low-energy vertebral compression fracture. A total of 72 (5.2%) children fulfilled these inclusion criteria; DNA samples were obtained for 66 of them. All 23 exons and exon-intron boundaries of the LRP5 gene were sequenced; the identified variants were analyzed in 235 healthy Finnish control samples. RESULTS: Sequencing revealed 15 coding region missense or silent variants with unknown functional consequences. No obvious loss-of-function mutations such as deletions, insertions, or changes resulting in premature termination codon or altered splicing were identified. Phenotyping of the proband and parents, and genotyping of the parents, in 9 families with novel or rare variants showed no obvious correlation between any of the LRP5 variants and fractures. CONCLUSIONS: Our study shows that in children LRP5 mutations are not a common cause of increased fractures. The observed rare LRP5 variants may together with unfavorable environmental and other genetic factors contribute to childhood fractures, but further studies are needed to confirm their functional significance and biological pathways through which this may occur. Our findings suggest that systematic LRP5 screening is not indicated in children with recurrent fractures.
机译:目的:最近的研究已经证实,低密度脂蛋白受体相关蛋白5基因(LRP5)在成年人的骨质积存和易患骨质疏松性骨折中起作用。这项研究评估了LRP5变异是否与儿童期骨折有关。患者和方法:在儿童骨折的流行病学研究中,包括1390名连续的芬兰急性骨折儿童,我们招募了容易骨折的4-16岁儿童,他们在年龄之前至少有两次低能量长骨骨折的病史在16岁之前进行10年或3次低能量长骨骨折,和/或至少1次低能量椎骨压缩性骨折。共有72名(5.2%)儿童达到了这些入选标准;获得其中的66个DNA样品。对LRP5基因的所有23个外显子和外显子-内含子边界进行了测序。在235个健康的芬兰对照样品中分析了鉴定出的变异体。结果:测序揭示了15个编码区错义或沉默变异,功能未知。没有发现明显的功能丧失突变,例如缺失,插入或改变导致过早终止密码子或改变了剪接。在具有新的或罕见的变异的9个家庭中,先证者和父母的表型以及父母的基因型显示,LRP5变异与骨折之间没有明显的相关性。结论:我们的研究表明,儿童中LRP5突变不是骨折增加的常见原因。观察到的罕见LRP5变异可能与不利的环境因素和其他遗传因素一起导致儿童期骨折,但还需要进一步研究以确认其功能意义和生物学途径。我们的发现表明,对于反复骨折的儿童,不建议进行系统的LRP5筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号